UNSPSC 51282902: Alatrofloxacin

This classification denotes a quinolone antibiotic and antimicrobial solution with the molecular formula C26H25F3N6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7QVV6I50DT, chemically known as l-alaninamide, l-alanyl-n-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl)-3-azabicyclo(3.1.0)hex-6-yl)-, (1alpha,5alpha,6alpha)- but generally known as alatrofloxacin, which bears US NIH Compound Identifier 3086677. Alatrofloxacin most often comes in base and mesylate forms.

UNSPSC 51282902 Alatrofloxacin is a Commodity code for a specific fluoroquinolone antibiotic, yet recent state and local procurement activity under this code centers on broader pharmaceutical procurement through piggyback contracts and cooperative purchasing vehicles rather than alatrofloxacin specifically. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both antibiotics but not alatrofloxacin—under an Invitation for Bid process. State and local health departments and county health agencies appear to be the primary issuing bodies, using cooperative purchasing vehicles and piggyback arrangements to procure packaged pharmaceutical inventory with defined expiration dates and quarterly or annual delivery schedules.

Activity under this code shows limited geographic diversity and sparse recent open solicitation volume. The two identifiable recent opportunities originate in Illinois (state health department) and Florida (county health system), both completed awards or expired bids rather than active solicitations. The Illinois contract, valued at $2,999,999.11 over the full three-year term including renewal options, awarded to Chartwell Rx LLC for a 12-month initial term with two one-year renewal options. The Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems (posted June 30, 2026, with a response deadline of July 26, 2026) sought 1,900 units annually with quarterly deliveries to the Seminole County Community Health Building; that procurement falls outside the nominal scope of alatrofloxacin but demonstrates state and local health procurement practices. Current activity suggests this code sees minimal recent open competition—most sourcing appears to flow through established piggyback and cooperative purchasing contracts rather than new individual competitive solicitations.